153 related articles for article (PubMed ID: 21978769)
1. Dysregulation of the Fas/FasL system in mononuclear cells recovered from peritoneal fluid of women with endometriosis.
Sturlese E; Salmeri FM; Retto G; Pizzo A; De Dominici R; Ardita FV; Borrielli I; Licata N; Laganà AS; Sofo V
J Reprod Immunol; 2011 Dec; 92(1-2):74-81. PubMed ID: 21978769
[TBL] [Abstract][Full Text] [Related]
2. Balanced regulation of mRNA production for Fas and Fas ligand in lymphocytes from centenarians: how the immune system starts its second century.
Pinti M; Troiano L; Nasi M; Bellodi C; Ferraresi R; Mussi C; Salvioli G; Cossarizza A
Circulation; 2004 Nov; 110(19):3108-14. PubMed ID: 15505087
[TBL] [Abstract][Full Text] [Related]
3. Regulation of fas ligand expression by IL-8 in human endometrium.
Selam B; Kayisli UA; Garcia-Velasco JA; Akbas GE; Arici A
J Clin Endocrinol Metab; 2002 Aug; 87(8):3921-7. PubMed ID: 12161534
[TBL] [Abstract][Full Text] [Related]
4. The contribution of the Fas/FasL apoptotic pathway in ulcer formation during Leishmania major-induced cutaneous Leishmaniasis.
Eidsmo L; Nylen S; Khamesipour A; Hedblad MA; Chiodi F; Akuffo H
Am J Pathol; 2005 Apr; 166(4):1099-108. PubMed ID: 15793290
[TBL] [Abstract][Full Text] [Related]
5. Serum soluble Fas (CD95) and Fas ligand profiles in chronic kidney failure.
Perianayagam MC; Murray SL; Balakrishnan VS; Guo D; King AJ; Pereira BJ; Jaber BL
J Lab Clin Med; 2000 Oct; 136(4):320-7. PubMed ID: 11039853
[TBL] [Abstract][Full Text] [Related]
6. Regulation of FAS ligand expression by chemokine ligand 2 in human endometrial cells.
Selam B; Kayisli UA; Akbas GE; Basar M; Arici A
Biol Reprod; 2006 Aug; 75(2):203-9. PubMed ID: 16687653
[TBL] [Abstract][Full Text] [Related]
7. Fas ligand is constitutively secreted by prostate cancer cells in vitro.
Liu QY; Rubin MA; Omene C; Lederman S; Stein CA
Clin Cancer Res; 1998 Jul; 4(7):1803-11. PubMed ID: 9676859
[TBL] [Abstract][Full Text] [Related]
8. The evaluation of soluble Fas and soluble Fas ligand levels of bronchoalveolar lavage fluid in lung cancer patients.
Erdoğan B; Uzaslan E; Budak F; Karadağ M; Ediger D; Oral B; Göral G; Ege E; Gözü O
Tuberk Toraks; 2005; 53(2):127-31. PubMed ID: 16100648
[TBL] [Abstract][Full Text] [Related]
9. Detection of Fas ligand in the bovine oviduct.
Bergqvist AS; Killian G; Erikson D; Hoshino Y; Båge R; Sato E; Rodríguez-Martínez H
Anim Reprod Sci; 2005 Mar; 86(1-2):71-88. PubMed ID: 15721660
[TBL] [Abstract][Full Text] [Related]
10. The alteration of Fas receptor and ligand system in hepatocellular carcinomas: how do hepatoma cells escape from the host immune surveillance in vivo?
Nagao M; Nakajima Y; Hisanaga M; Kayagaki N; Kanehiro H; Aomatsu Y; Ko S; Yagita H; Yamada T; Okumura K; Nakano H
Hepatology; 1999 Aug; 30(2):413-21. PubMed ID: 10421649
[TBL] [Abstract][Full Text] [Related]
11. ROS-mediated p38alpha MAPK activation and ERK inactivation responsible for upregulation of Fas and FasL and autocrine Fas-mediated cell death in Taiwan cobra phospholipase A(2)-treated U937 cells.
Liu WH; Cheng YC; Chang LS
J Cell Physiol; 2009 Jun; 219(3):642-51. PubMed ID: 19180563
[TBL] [Abstract][Full Text] [Related]
12. Fas/Fas ligand interactions are involved in ultraviolet-B-induced human lymphocyte apoptosis.
Caricchio R; Reap EA; Cohen PL
J Immunol; 1998 Jul; 161(1):241-51. PubMed ID: 9647230
[TBL] [Abstract][Full Text] [Related]
13. IL-13 and TH2 cytokine exposure triggers matrix metalloproteinase 7-mediated Fas ligand cleavage from bronchial epithelial cells.
Wadsworth SJ; Atsuta R; McIntyre JO; Hackett TL; Singhera GK; Dorscheid DR
J Allergy Clin Immunol; 2010 Aug; 126(2):366-74, 374.e1-8. PubMed ID: 20624652
[TBL] [Abstract][Full Text] [Related]
14. The expression of Fas/FasL and apoptosis in yak placentomes.
JiangFeng F; Jiu YS; Wen ZZ; Ben L
Anim Reprod Sci; 2011 Oct; 128(1-4):107-16. PubMed ID: 22014664
[TBL] [Abstract][Full Text] [Related]
15. Significance of Fas and Fas ligand in tuberculous lymphadenitis.
Mustafa T; Mogga SJ; Mfinanga SG; Mørkve O; Sviland L
Immunology; 2005 Feb; 114(2):255-62. PubMed ID: 15667570
[TBL] [Abstract][Full Text] [Related]
16. Analysis of cytotoxic T lymphocytes and Fas/FasL in Japanese patients with non-small cell lung cancer associated with HLA-A2.
Yoshimura C; Nomura S; Kanazawa S; Kuwana M; Muramatsu M; Yamaguchi K; Fukuhara S
J Cancer Res Clin Oncol; 2002 Nov; 128(11):581-8. PubMed ID: 12458337
[TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of CD95 and CD69 molecules among CD56 cells in women with endometriosis.
Eidukaite A; Siaurys A; Tamosiunas V
Am J Reprod Immunol; 2006 Apr; 55(4):276-81. PubMed ID: 16533339
[TBL] [Abstract][Full Text] [Related]
18. Serum DNase I, soluble Fas/FasL levels and cell surface Fas expression in patients with SLE: a possible explanation for the lack of efficacy of hrDNase I treatment.
Tinazzi E; Puccetti A; Gerli R; Rigo A; Migliorini P; Simeoni S; Beri R; Dolcino M; Martinelli N; Corrocher R; Lunardi C
Int Immunol; 2009 Mar; 21(3):237-43. PubMed ID: 19181929
[TBL] [Abstract][Full Text] [Related]
19. A possible role of Fas-ligand-mediated "reverse signaling" in pathogenesis of rheumatoid arthritis and systemic lupus erythematosus.
Telegina E; Reshetnyak T; Moshnikova A; Proussakova O; Zhukova A; Kuznetsova A; Ivanov A; Paltsev M; Beletsky I
Immunol Lett; 2009 Jan; 122(1):12-7. PubMed ID: 19010354
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus core protein inhibits Fas-mediated apoptosis of hepatoma cells via regulation of mFas/FasL and sFas expression.
Liu W; Lin YT; Yan XL; Ding YL; Wu YL; Chen WN; Lin X
FASEB J; 2015 Mar; 29(3):1113-23. PubMed ID: 25466893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
